Abacavir, dolutegravir, and lamivudine and Icatibant Subcutaneous
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Icatibant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: icatibant
Brand name: Firazyr
Synonyms: Icatibant
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-ICG for Injection Set
- Abacavir, dolutegravir, and lamivudine-Iclevia
- Abacavir, dolutegravir, and lamivudine-Iclusig
- Abacavir, dolutegravir, and lamivudine-Icosapent
- Abacavir, dolutegravir, and lamivudine-Icosapent ethyl
- Abacavir, dolutegravir, and lamivudine-Icosapent Ethyl Capsules
- Icatibant Subcutaneous-Abacavir, Lamivudine and Zidovudine Tablets
- Icatibant Subcutaneous-Abacavir, lamivudine, and zidovudine
- Icatibant Subcutaneous-Abaloparatide
- Icatibant Subcutaneous-Abaloparatide Subcutaneous
- Icatibant Subcutaneous-Abatacept
- Icatibant Subcutaneous-Abatacept Auto-Injectors